International Conference on Advances in Radiation Oncology (ICARO): Outcomes of an IAEA Meeting
- Equal contributors
1 STUK, Finnish Radiation and Nuclear Safety Authority and Dept. of Radiation Oncology Turku University Hospital, Finland
2 Department of Nuclear Sciences and Applications, Division of Human Health, International Atomic Energy Agency, P.O. Box 100, Vienna, Austria
3 Department of Radiation Oncology, Northwestern University, 1653 W. Congress Pkwy, Chicago, IL 60612, USA
4 Radiological Physics Center, UT M.D. Anderson Cancer Center, Box 547, 1515 Holcombe Blvd Houston, TX 77030, USA
5 Dept. of Radiation Oncology, Wayne State University School of Medicine, Gershenson Radiation Oncology Center, 4100 John R. Detroit, MI 48201-2013
Radiation Oncology 2011, 6:11 doi:10.1186/1748-717X-6-11Published: 4 February 2011
The IAEA held the International Conference on Advances in Radiation Oncology (ICARO) in Vienna on 27-29 April 2009. The Conference dealt with the issues and requirements posed by the transition from conventional radiotherapy to advanced modern technologies, including staffing, training, treatment planning and delivery, quality assurance (QA) and the optimal use of available resources. The current role of advanced technologies (defined as 3-dimensional and/or image guided treatment with photons or particles) in current clinical practice and future scenarios were discussed.
ICARO was organized by the IAEA at the request of the Member States and co-sponsored and supported by other international organizations to assess advances in technologies in radiation oncology in the face of economic challenges that most countries confront. Participants submitted research contributions, which were reviewed by a scientific committee and presented via 46 lectures and 103 posters. There were 327 participants from 70 Member States as well as participants from industry and government. The ICARO meeting provided an independent forum for the interaction of participants from developed and developing countries on current and developing issues related to radiation oncology.